Liberty Insurance Underwriters Inc. v. Cocrystal Pharma Inc.
Case Number:
1:19-cv-02281
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 28, 2023
Pharma Co., Insurer Settle Fight Over Market Fraud Suits
A pharmaceutical company and its insurer have settled a dispute over coverage of several suits brought against the company by stockholders following a subpoena and investigation by the U.S. Securities and Exchange Commission.
-
September 05, 2023
Market Fraud Suits Should Be Covered, Pharma Co. Says
A pharmaceutical company told a Delaware federal court that several lawsuits brought against it by stockholders following a subpoena and investigation by the U.S. Securities and Exchange Commission should be deemed to have been made during its policy period, arguing that provisions in the insurance policy extend coverage.
-
March 29, 2023
3rd Circ. Orders Trial In Pharma Fraud Coverage Suit
The Third Circuit on Wednesday revived an insurer's suit seeking to avoid paying $1.1 million in defense costs for a U.S. Securities and Exchange Commission investigation of a pharmaceutical company facing allegations its executives engaged in stock manipulation before the company came into existence, clearing the case for trial.
-
May 23, 2022
Judge Channels Pacino While Handing Insurer Coverage Win
A Liberty Mutual unit owes no coverage to a pharmaceutical company facing allegations its directors and officers engaged in stock manipulation before the company came into existence, a Delaware federal judge ruled Monday, quoting Al Pacino to hammer home his point about straightforwardness in policy language.
-
March 04, 2022
Insurer Says Pharma Co.'s Market Fraud Suits Not Covered
A pharmaceutical company facing allegations that it and some of its current and former officers engaged in stock manipulation before the company came into existence in a reverse merger is not entitled to coverage, a Liberty Mutual unit said, opposing the company's bid for summary judgment.
-
February 10, 2022
Pharma Co. Says Insurer Must Cover Stock Manipulation Suits
A Liberty Mutual unit cannot deny coverage to a pharmaceutical company facing suits that accuse it and some of its current and former executives of engaging in stock manipulation before the company came into existence in a reverse merger, the company argued to a Delaware federal court.